Otsuka Pharmaceutical Co., Ltd.
Nutraceuticals
July 14, 2022
Introducing New B240 Tablets
Effortless way to consume a unique ingredient for maintenance of physical condition
Otsuka Pharmaceutical Co., Ltd. will launch B240 Tablets, offering a convenient new way to consume lactic acid bacterium B240, a proprietary Otsuka ingredient that supports maintenance of physical condition. The new B240 Tablets were launched July 14, 2022 through the 'otsuka-plus1.com' e-commerce portal.
In recent years, changes in the social environment leading to the emergence of new health-consciousness and increased interest in managing physical condition have fueled expansion of the market for products related to conditioning support. Among such products, it has been reported that ongoing consumption of lactic acid bacteria, which is closely related to digestive functions, helps to support maintenance of physical condition.
New B240 Tablets are a supplement containing plant-based lactic acid bacterium B240, confirmed to be effective through long-term research into the relationship between lactic acid bacteria and the digestive tract. Products under the BODYMAINTÉ brand contain lactic acid bacterium B240 to support day-to-day conditioning. New B240 Tablets are small, easy-to-swallow tablets conceived to encourage ongoing consumption of this same lactic acid bacteria. The new tablets offer strong support for those who wish to maintain physical condition amidst the many health-related risks of modern society.
・An easy way to consume plant-based lactic acid bacterium B240 to support optimum physical condition.
・One tablet contains 2 billion counts of lactic acid bacterium B240.
・Intake of a single small-sized tablet per day makes it easy to continue use as a lactic acid bacterium B240 supplement.
The Otsuka Pharmaceutical Otsu Nutraceuticals Research Institute is engaged in research regarding the functions of lactic acid bacteria based on the theme of mucosal immunity. B240 is a plant-based lactic acid bacteria with efficacy for maintaining physical condition confirmed through many years of research concerning the digestive tract and lactic acid bacteria. B240 was isolated by Tokyo University of Agriculture from miang, a form of fermented tea traditionally consumed in northern Thailand, with efficacy for enhancing biological defense mechanisms confirmed by Otsuka Pharmaceutical. As a lactic acid bacteria that offers protective functions, B240 is incorporated in a variety of products that contribute to health and well-being.
otsuka-plus1 e-commerce portal:
https://www.otsuka-plus1.com/shop/c/c3086/（in Japanese）
Product Information
| Product name |
B240 Tablets |
|
|---|---|---|
| Category |
Food containing lactic acid |
|
| Ingredients |
Lactose （US-processed）, corn starch, lactic acid bacteria/cellulose, calcium stearate |
|
| Content |
6g （200mg×30 tablets） |
|
| Recommended daily intake | 1 tablet / day | |
| Price（tax inclusive） | ¥2,268 | |
|
Nutrition Per single （0.2g） tablet |
|
|
|
Lactic acid bacterium B240, 2 billion counts |
||
| Shelf-life | 24 months |
Based on the corporate philosophy of 'Otsuka - people creating new products for better health worldwide,' Otsuka Pharmaceutical continues to contribute to the health and well being of people around the world.